Internal Medicine, Medical Oncology · Tampa, FL
NPI
1992096028
Since 2011
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
12902 Usf Magnolia Dr
Tampa, FL, 33612
Phone (813) 745-6895
Groups this clinician bills Medicare through
Medicare paid, 2024
$56K
616 services
Medicare patients, 2024
273
Average age 74
Drug cost, 2024
$4.8M
1,226 prescriptions
Company payments, 2025
$4,248
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael R Shafique was code 99214 (office e&m - established), 324 times for 159 patients. In total Michael R Shafique billed 616 services in 8 codes, and Medicare paid $56K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-02-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 324 | 159 | $75.84 | $25K |
| 99215 Office E&M - Established | Office | 145 | 94 | $110.23 | $16K |
| 99205 Office E&M - New | Office | 78 | 78 | $139.78 | $11K |
| 99204 Office E&M - New | Office | 22 | 22 | $108.40 | $2,385 |
| 99214 Office E&M - Established | Facility | 17 | 16 | $53.73 | $913 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 16 | 13 | $12.97 | $208 |
By year: 2022 $70K for 686 services; 2023 $67K for 656 services; 2024 $56K for 616 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael R Shafique prescribed most often to Medicare patients was Tagrisso (Osimertinib Mesylate), with 112 prescriptions and refills. In total Michael R Shafique wrote 1,226 Medicare prescriptions that cost $4.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tagrisso Osimertinib Mesylate | 112 | 112 | 15 | $2.0M |
| Prednisone Generic | 97 | 119 | 24 | $318 |
| Oxycodone Hcl Generic | 93 | 101 | 23 | $2,063 |
| Dexamethasone Generic | 86 | 111 | 61 | $2,179 |
| Prochlorperazine Maleate Generic | 82 | 82 | 63 | $1,756 |
| Ondansetron Hcl Generic | 75 | 76 | 50 | $1,760 |
| Tramadol Hcl Generic | 35 | 35 | 18 | $418 |
| Levothyroxine Sodium Generic | 34 | 72 | 12 | $270 |
| Methylprednisolone Generic | 27 | 27 | 17 | $304 |
| Alecensa Alectinib Hcl | 25 | 30 | Under 11 | $430K |
| Gilotrif Afatinib Dimaleate | 23 | 23 | Under 11 | $258K |
| Lorbrena Lorlatinib | 23 | 23 | Under 11 | $488K |
| Lumakras Sotorasib | 22 | 22 | Under 11 | $409K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 22 | 22 | Under 11 | $597 |
| Sertraline Hcl Generic | 20 | 46 | Under 11 | $139 |
Brand drugs: 329 claims; generic drugs: 897 claims; opioid claims: 169.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael R Shafique $4,248 ($4,248 in general payments such as food, travel and fees) from 6 companies. The largest payer was Roche Diagnostics Corporation with $4,248.
| Company | Payments | Amount |
|---|---|---|
| Roche Diagnostics Corporation ROG.SW | 6 | $4,248 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.